Convenient New Purchasing Solution Available in 17 States with More to be Added Soon
TAMPA, FL / ACCESSWIRE / December 8, 2020 / Trxade Group, Inc. (NASDAQ:MEDS), an integrated drug procurement, delivery and healthcare platform, today announced the launch of Trxade Prime, a revolutionary service offered by the Company's Integra Pharma Solutions subsidiary.
Trxade Prime solves a historic problem for independent pharmacies suffering from an already complex prescription distribution process. This solution allows the 11,800 independent pharmacies members on the Trxade platform to process, consolidate and ship purchase orders that are placed directly with Trxade Suppliers via the Trxade Prime Service. This dramatically increases time savings and eliminates cost burdens that are typically faced by independent pharmacy businesses.
"The mission of Trxade, from its inception, has been to empower and encourage growth within the Independent Pharmacy community," said Suren Ajjarapu, Founder and Chief Executive Officer of Trxade Group. "The development of Trxade Prime was the result of feedback from our significant pharmacy member base on ways to enhance purchasing efficiencies and cost savings. The overwhelming feedback Trxade received include the difficulties pharmacies face meeting multiple supplier requirements on order minimums, individual invoicing with vastly varied payment terms and the lack of consolidated information with regard to tracking multiple orders with differing delivery dates, times and shipping costs.
"We are confidently launching the Trxade Prime service to our members at no cost, with the goal of offering a single tool with one low order minimum, one invoice, one package and one delivery from multiple quality wholesalers and distributors. Trxade Prime will empower pharmacies to leverage their buying potential and maximize their savings in the marketplace by making it extremely easy to place orders with multiple suppliers in real time. The feedback we are receiving is exceptional and we anticipate further expansion of the Trxade Prime service nationally and to further include many of our top-rated network of ADR/VAWD certified pharmaceutical suppliers," concluded Ajjarapu.
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (Nasdaq:MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; (1) the Trxade B2B trading platform with around 11,800 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group's virtual wholesale division, and (3) the Bonum Health platform offering affordable telehealth services. For additional information, please visit us at www.trxade.com or at www.bonumhealth.com.
Forward-Looking Statements
This press release may contain forward-looking statements, including information about management's view of Trxade's future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the "Act"). In particular, when used in the preceding discussion, the words "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions are intended to identify forward-looking statements within the meaning of the Act, and are subject to the safe harbor created by the Act. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of Trxade, its divisions and concepts to be materially different than those expressed or implied in such statements. These risk factors and others are included from time to time in filings made by Trxade with the Securities and Exchange Commission, including, but not limited to, in the "Risk Factors" sections in its Form 10-Ks and Form 10-Qs and in its Form 8-Ks, which it has filed, and files from time to time, with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov. Other unknown or unpredictable factors also could have material adverse effects on Trxade's future results and/or could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. Trxade cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
Investor Relations:
Luke Zimmerman
Senior Vice President
MZ Group - MZ North America
(949) 259-4987
MEDS@mzgroup.us
www.mzgroup.us
SOURCE: Trxade Group, Inc.
View source version on accesswire.com:
https://www.accesswire.com/619831/Trxade-Group-Launches-Trxade-Prime-Purchasing-Solution-to-Simplify-Prescription-Distribution
